Literature DB >> 3757192

Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man.

J B Meddings, J M Dietschy.   

Abstract

At the present time the most useful technique with which to examine the kinetics of low-density lipoprotein (LDL) cholesterol in vivo is the labeled LDL turnover study. However, a major limitation of this method is that, despite its ability to accurately measure both the plasma LDL concentration and LDL production rate, it cannot directly quantify LDL receptor activity. The present study defines the equations that describe the relationship between LDL cholesterol production rate, LDL receptor number, and plasma LDL cholesterol concentration. These equations provide a method that allows calculation of total LDL receptor activity based on the results of an LDL turnover study. With the use of this technique and data from previously published series, the effects of the genetic absence of receptors, aging, and the treatment of hypercholesterolemia with mevinolin on LDL cholesterol kinetics were analyzed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757192     DOI: 10.1161/01.cir.74.4.805

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.

Authors:  E Gherardi; D E Bowyer; C Fitzsimmons; T Le Cras; A Hutchings; G Butcher
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

2.  Influence of age on the metabolism of plasma low density lipoproteins in healthy males.

Authors:  S Ericsson; M Eriksson; S Vitols; K Einarsson; L Berglund; B Angelin
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

3.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. I. Tracer purification, in vitro and in vivo long-term stability, in vitro validation and biodistribution.

Authors:  T Leitha; M Hermann; M Hüttinger; P Angelberger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

5.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results.

Authors:  T Leitha; A Staudenherz; B Gmeiner; M Hermann; M Hüttinger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

6.  Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.

Authors:  T L Innerarity; K H Weisgraber; K S Arnold; R W Mahley; R M Krauss; G L Vega; S M Grundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody.

Authors:  C Fitzsimmons; R Bush; D Hele; C Godliman; E Gherardi; D E Bowyer
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

8.  Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma.

Authors:  M Eriksson; L Berglund; M Rudling; P Henriksson; B Angelin
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

9.  Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.

Authors:  Y Osono; L A Woollett; J Herz; J M Dietschy
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Regulation of plasma LDL: the apoB paradigm.

Authors:  Allan D Sniderman; Jacqueline De Graaf; Patrick Couture; Ken Williams; Robert S Kiss; Gerald F Watts
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.